MaxCyte, Inc.
MXCT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -6.4% | -6.7% | 30.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 81.6% | 88.5% | 88.5% | 89.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -120.1% | -106.9% | -55.7% | -49% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -106.3% | -91.8% | -53.3% | -56.3% |
| EPS Diluted | -0.39 | -0.37 | -0.19 | -0.22 |
| % Growth | -5.4% | -94.7% | 13.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |